Overview

A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of three intra-articular injections, given 2 weeks apart, of Ampion™ in Adults with pain due to osteoarthritis of the knee.
Phase:
Phase 3
Details
Lead Sponsor:
Ampio Pharmaceuticals. Inc.